RedHill Biopharma : Announces First Patient Enrolled in U.S. Government- Supported COVID-19 Study - Form 6-K
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K ...
Source: marketscreener.com
Nuclear Countermeasures Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Nuclear Countermeasures Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Nuclear Countermeasures Program Today - Breaking & Trending Today
RedHill Biopharma : and U.S. Army Announce Opaganib and RHB-107 Combinations with Remdesivir Show Distinct Synergistic Effect Against Ebola - Form 6-K -December 20, 2023 at 08:58 am EST
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K ...
Source: marketscreener.com
Why Is RedHill Biopharma (RDHL) Stock Surging Today? - Redhill Biopharma (NASDAQ:RDHL)
RedHill Biopharma Ltd (NASDAQ: RDHL) says opaganib and RHB-107 (upamostat) demonstrated robust synergistic effects when combined individually with Gilead Sciences Inc (NASDAQ: GILD) Veklury (remdesivir) i
Source: benzinga.com
RedHill Announces New, Non-Dilutive External Funding of Entire RHB-107 COVID-19 300-Patient Phase 2 Study
RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced new non-dilutive external funding, additional to the previously announced U.S. Government funding, which now covers the entirety of the RHB-107 (upamostat) arm of the ACESO PROTECT adaptive platform trial for early COVID-19 outpatient treatment. This additional funding amounts to approximately $4.8M directed towards evaluation of RHB-107 in the PROTECT study.
Source: yahoo.com
Israel-Based Penny Stock RedHill Biopharma Is Trading Higher Today - Here's Why? - Redhill Biopharma (NASDAQ:RDHL)
RedHill Biopharma Ltd (NASDAQ: RDHL) shares are trading higher after the company said that its oral opaganib shows a significant increase in survival time (at 150 mg/kg twice daily dose) in a U.S.
Source: benzinga.com